Renal and vascular physiology and phisiopathology

2025 Activity indicators

6 competitive national public projects: ISCIII, CAM UAH

1 private project led
3 competitive HR contracts
8 publications
Impact Factor: 35.30
Publications in Q1: 6 (75%)
3 doctoral theses supervised and defended
4 awards
1 Spanish patent granted (ES 2 892 025 B2) in the process of international extension via PCT, which corresponds to ligands modulating integrin-linked kinase and their use for the treatment of diseases
Evaluators from national public agencies and entities: 5 researchers
2 visiting researchers hosted for stays of more than 1 month: Institute of Clinical Physiology (Italy) & Pontifical Catholic University of Valparaíso (Chile)

Ongoing funding from the Carlos III Health Institute, with 3 active projects (PI22/01714, PI23/01071, PMPTA23/00033), participation in the RICORS2040-Renal network, and two PFIS predoctoral contracts.
Defense of the doctoral thesis entitled "Role of calpains in the progression of kidney disease and associated sarcopenia," by Elena Gutiérrez Calabrés, with international distinction, reflecting the training capacity and international reach of the research group.
Regular collaboration with private companies for the development of R&D&I activities (Graphenano Medical Care, Intelligent Data, Nipro Medical Europe).
"Santiago Ramón y Cajal" Diploma from the Spanish National Research Council (CSIC) for clinical research merit, awarded to Dr. Diego Rodríguez Puyol.
Participation in the main national research consortia, such as RICORS 2040, funded by the Carlos III Health Institute, and the Community of Madrid, INNOREN-CM Consortium (P2022/BMD7221), "New diagnostic and therapeutic strategies in chronic kidney disease".

	Articles	Accum. FI	Mean FI	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2021	13	81.62	6.28	12	92	5	38
2022	4	29.39	7.35	4	100	1	25
2023	4	27.30	6.83	4	100	1	25
2024	4	21.90	5.48	4	100	0	0
2025	8	35.30	4.41	8	100	0	0
	33	195.51	6.07	32	97	7	21